Entera Bio Ltd. ENTXW 深 滬
等待開盤 08-13 09:30:00 美东时间
0.0012
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.0012
- 總市值 2.85万
- 52周最高 0.328
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.00
- 委 比 0.00%
- 總股本 2373.86万
- 歷史最高 1.90
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.00
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Entera Bio Receives FDA Agreement To Support EB613 NDA Filing With Single 24-Month Global Phase 3 Study In Postmenopausal Osteoporosis, Using Total Hip BMD As Primary Endpoint And Vertebral Fracture Incidence As Key Secondary
Entera Bio Ltd. (NASDAQ:ENTX), a leader in the development of oral peptides and protein replacement therapies, announced today that in a written response to a Type A meeting request, the U.S. Food and Drug Administration
07-28 19:32
OPKO Health And Entera Bio Say New Pharmacologic And Pharmacokinetic In Vivo Data For Investigational Oral OPK-88006 Tablet Treatment Selected For Presentation At ENDO 2025 Annual Meeting
OPKO Health, Inc. (NASDAQ:OPK) and Entera Bio Ltd. (NASDAQ:ENTX) ("Entera") today announced that new pharmacologic and pharmacokinetic in vivo data for investigational oral OPK-88006 tablet treatment has been selected
06-25 20:12
Entera Bio Reports Transformative Year in 2024
Entera Bio ( ($ENTX) ) has released its Q4 earnings. Here is a breakdown of the...
03-29 11:57
Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
Entera Bio Ltd. (NASDAQ:ENTX, ", Entera", )))) and OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. (NASDAQ:OPK, ", OPKO", )))) have entered into a Research Collaboration Agreement. Under the terms
2023-09-12 20:32
Bioventus And 3 Other Stocks Under $5 Insiders Are Buying
The Dow Jones closed lower by 175 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
2023-08-23 21:23
Entera Bio Ltd.（纳斯达克股票代码：ENTX）首席执行官米兰达·杰恩·托莱达诺收购了3万股股票
Entera Bio Ltd. (NASDAQ:ENTX – Get Rating) CEO Miranda Jayne Toledano bought 30...
2023-04-07 20:32
Entera Bio Ltd.（纳斯达克股票代码：ENTX）预计2023年第一季度每股收益为0.12美元
Entera Bio Ltd. (NASDAQ:ENTX – Get Rating) – Analysts at HC Wainwright boosted ...
2023-04-07 14:04
HC Wainwright预测，Entera Bio Ltd.（纳斯达克股票代码：ENTX）将公布2024年第一季度每股收益（0.23美元）
Entera Bio Ltd. (NASDAQ:ENTX – Get Rating) – Equities research analysts at HC W...
2023-04-06 14:01
Entera Bio Ltd.（纳斯达克股票代码：ENTX）3月份空头利率上涨114.4％
Entera Bio Ltd. (NASDAQ:ENTX – Get Rating) was the recipient of a large growth ...
2023-03-29 05:52
Entera Bio Ltd.（纳斯达克股票代码：ENTX）2月份空头利率上涨181.5％
Entera Bio Ltd. (NASDAQ:ENTX – Get Rating) was the recipient of a significant g...
2023-03-11 06:25
